Shares of Avacta Group Plc (LON:AVCT – Get Free Report) were down 8.2% on Tuesday . The company traded as low as GBX 64.03 ($0.85) and last traded at GBX 64.25 ($0.85). Approximately 246,493 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 2,372,630 shares. The stock had previously closed at GBX 70 ($0.92).
Avacta Group Stock Performance
The company has a quick ratio of 4.96, a current ratio of 0.62 and a debt-to-equity ratio of 191.87. The stock has a market capitalization of £231.57 million, a PE ratio of -716.67 and a beta of 1.12. The firm has a 50 day moving average price of GBX 70.67 and a 200-day moving average price of GBX 56.42.
Insider Buying and Selling
In other Avacta Group news, insider Tony Peter Gardiner sold 500,000 shares of Avacta Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of GBX 71 ($0.94), for a total transaction of £355,000 ($468,956.41). 32.90% of the stock is owned by corporate insiders.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- What Are Some of the Best Large-Cap Stocks to Buy?
- How Much Can You Make in Stocks in One Month?
- Breakout Stocks: What They Are and How to Identify Them
- This Is the Top Large-Cap Stock Insiders Are Buying
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
